Pregled bibliografske jedinice broj: 627594
Comparative analysis of price dynamics of original and generic simvastatine and atorvastatine and the discount factor applicable in the Croatia
Comparative analysis of price dynamics of original and generic simvastatine and atorvastatine and the discount factor applicable in the Croatia // Konačni program i sažeci Trećeg hrvatskog i trećeg jadranskog kongresa farmakoekonomike i istraživanja ishoda liječenja / Pharmaca : hrvatski časopis za farmakoterapiju, suppl. 2013
Zagreb: Hrvatsko društvo za kliničku farmakologiju i terapiju, 2013. str. 55-55 (predavanje, podatak o recenziji nije dostupan, sažetak, znanstveni)
CROSBI ID: 627594 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Comparative analysis of price dynamics of original
and generic simvastatine and atorvastatine and the
discount factor applicable in the Croatia
Autori
Vitezić, Neda ; Lovrić, Ljiljana ; Kučan, Marta
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Konačni program i sažeci Trećeg hrvatskog i trećeg jadranskog kongresa farmakoekonomike i istraživanja ishoda liječenja / Pharmaca : hrvatski časopis za farmakoterapiju, suppl. 2013
/ - Zagreb : Hrvatsko društvo za kliničku farmakologiju i terapiju, 2013, 55-55
Skup
Treći hrvatski i treći jadranski kongres farmakoekonomike i istraživanja ishoda liječenja
Mjesto i datum
Brijuni, Hrvatska, 25.04.2013. - 27.04.2013
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Podatak o recenziji nije dostupan
Ključne riječi
C-10 statine ; real prices ; discount rate
Sažetak
The starting point of this analysis is a scientifically established fact that the real price of brand name and generic drugs drops according to the length of the implementation period. This fact was tested on the example of the 25 most prescribed drugs in the Republic of Croatia in the period of 2008 to 2012., and especially on the two most prescribed drugs groups from the ATC C-10 drug group (simvastatine and atorvastatine). The aim of this research is to determine the difference between the prices of the 25 most prescribed drugs in the Republic of Croatia and the most prescribed drugs group from the C-10 group (simvastatine and atorvastatine), and also to determine whether there are differences in the actual dynamics of drug prices in comparison to the estimated discount rate account using CAPM (Capital Asset Price Model). It will also be determined whether there are differences in population dynamics, current prices and real prices adjusted for the dynamics of the producer prices of the pharmaceutical products and preparations (statistical data). C-10 statine, real prices, discount rate
Izvorni jezik
Engleski
Znanstvena područja
Ekonomija
POVEZANOST RADA
Projekti:
MZOS-062-0620063-0060 - Uporaba kardiovaskularnih lijekova i značaj farmakoekonomskih procjena (Vitezić, Dinko, MZOS ) ( CroRIS)
081-0000000-1280 - Korporativno upravljanje i poslovna uspješnost
Ustanove:
Ekonomski fakultet, Rijeka
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus